Crossmark

Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women with Ovarian Cancer

Published Online: 2024-01-16

Published Print: 2024-03

Authors

Hassani, Shahrzad Sheikh

Moradpanah, Somayeh

Akhavan, Setare

Mousavi, Azamsadat

Zamani, Narges

Rezayof, Elahe
Funding

Funding for this research was provided by:

Tehran University of Medical Sciences and Health Services
License Information

Text and Data Mining valid from 2024-01-16

Version of Record valid from 2024-01-16
More Information

Article History

Received: 9 May 2023

Revised: 26 November 2023

Accepted: 28 November 2023

First Online: 16 January 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current